CS 2100

CAS No. 913827-99-3

CS 2100( 1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-3-azetidinecarboxylic acid )

Catalog No. M27618 CAS No. 913827-99-3

CS 2100 is an S1P1 agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 33 In Stock
5MG 55 In Stock
10MG 88 In Stock
25MG 178 In Stock
50MG 275 In Stock
100MG 405 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CS 2100
  • Note
    Research use only, not for human use.
  • Brief Description
    CS 2100 is an S1P1 agonist.
  • Description
    CS 2100 is an S1P1 agonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-3-azetidinecarboxylic acid
  • Pathway
    GPCR/G Protein
  • Target
    S1P Receptor
  • Recptor
    sEH
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    913827-99-3
  • Formula Weight
    461.54
  • Molecular Formula
    C25H23N3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 12.5 mg/mL (27.08 mM)
  • SMILES
    CCc1cc(CN2CC(C2)C(O)=O)sc1-c1noc(n1)-c1ccc(Oc2ccccc2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Podolin PL, et al. In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor. Prostaglandins Other Lipid Mediat. 2013 Jul-Aug;104-105:25-31.
molnova catalog
related products
  • VPC 23019

    VPC 23019 is a competitive antagonist at the S1P1 and S1P3 receptors (pKi= 7.86 and 5.93, respectively).

  • 4-Deoxypyridoxine hy...

    4-Deoxypyridoxine (hydrochloride) inhibits the degradation of intracellular S1P by inhibiting S1P lyase (SPL) activity, minimized the chemically induced apoptosis of insulinoma cell lines as S1P did.

  • CYM 5520

    noncompetitive allosteric agonist of S1P2.